marketcap
Facebook
Twitter
Telegram
Report an ErrorAkers Biosciences, Inc. Financial Ratios 2011-2024 | AKER
Annual Financial Ratios Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.0 | -0.2 | -0.6 | -0.2 | -1.0 | -0.3 | -2.6 | -2.7 | - | - |
P/S |
- | 0.6 | 3.8 | 0.3 | 1.1 | 1.5 | 1.8 | 1.2 | - | - |
EV/EBITDA |
-0.0 | -0.1 | -0.7 | -0.2 | -0.7 | -0.4 | -2.6 | -2.6 | - | - |
PEG |
-0.0 | -0.0 | -0.01 | 0.0 | -0.01 | 0.0 | -0.08 | -0.07 | - | - |
P/B |
0.0 | 0.1 | 1.1 | 0.1 | 1.0 | 0.5 | 0.5 | 1.0 | - | - |
P/CF |
-0.1 | -0.3 | -0.7 | -0.2 | -0.8 | -0.6 | -2.0 | -1.5 | - | - |
ROE % |
-50.84 | -41.56 | -185.97 | -63.70 | -97.52 | -141.02 | -21.12 | -37.04 | - | - |
ROA % |
-161.51 | -35.72 | -138.96 | -53.32 | -64.96 | -112.57 | -18.78 | -25.13 | - | - |
ROCE % |
-131.33 | -40.67 | -146.65 | -55.44 | -136.62 | -106.80 | -21.64 | -43.93 | - | - |
DSO |
- | 9.9 | 38.6 | 150.1 | 78.1 | 127.1 | 191.8 | 211.9 | - | - |
DIO |
- | 66.1 | 138.9 | 474.3 | 686.3 | 434.4 | 281.1 | 195.5 | - | - |
DPO |
- | 218.4 | 162.9 | 254.2 | 372.5 | 206.7 | 113.1 | 118.8 | - | - |
All numbers in USD currency